Applied Genetic Technologies reported $21.71M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Alimera Sciences ALIM:US $ 11.4M 1.09M
Applied Genetic Technologies AGTC:US $ 21.71M 2M
Avrobio Inc AVRO:US $ 22.79M 5.84M
Biogen BIIB:US $ 4211.6M 864.4M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Celldex Therapeutics CLDX:US $ 14.18M 0.31M
Cti Biopharma CTIC:US $ 62.34M 46.55M
Gilead Sciences GILD:US $ 10245M 31M
Insmed INSM:US $ 112.5M 12.84M
Life Technologies LIFE:US $ 5.82M 1.46M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Rigel Pharmaceuticals RIGL:US $ 59.28M 0.26M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M